The table below shows BIODESIX INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$10.17M
-$8.60M
-$15.31M
-$7.69M
-$13.10M
-$11.33M
Capital expenditure
$81.00K
$74.00K
$234.00K
$7.68M
$262.00K
$466.00K
Investing cash flow
-$144.00K
-$137.00K
-$273.00K
-$7.71M
-$352.00K
-$516.00K
Dividends paid
-
-
-
BDSX operating cash flow (10-K history)
BIODESIX INC reported operating cash flow of -$23.27M for fiscal year 2025. That is up 52.2% from -$48.65M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$21.73M (FY 2019) to -$23.27M. Figures come from the company's audited annual reports as filed with the SEC.